Cargando…
Application of CRISPR genetic screens to investigate neurological diseases
The adoption of CRISPR-Cas9 technology for functional genetic screens has been a transformative advance. Due to its modular nature, this technology can be customized to address a myriad of questions. To date, pooled, genome-scale studies have uncovered genes responsible for survival, proliferation,...
Autores principales: | So, Raphaella W. L., Chung, Sai Wai, Lau, Heather H. C., Watts, Jeremy J., Gaudette, Erin, Al-Azzawi, Zaid A. M., Bishay, Jossana, Lin, Lilian Tsai-Wei, Joung, Julia, Wang, Xinzhu, Schmitt-Ulms, Gerold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857349/ https://www.ncbi.nlm.nih.gov/pubmed/31727120 http://dx.doi.org/10.1186/s13024-019-0343-3 |
Ejemplares similares
-
The aminoglycoside G418 hinders de novo prion infection in cultured cells
por: Arshad, Hamza, et al.
Publicado: (2021) -
Tau interactome analyses in CRISPR-Cas9 engineered neuronal cells reveal ATPase-dependent binding of wild-type but not P301L Tau to non-muscle myosins
por: Wang, Xinzhu, et al.
Publicado: (2019) -
Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression
por: Ruiz-Riquelme, Alejandro, et al.
Publicado: (2018) -
CRISPR-Cas9-Based Knockout of the Prion Protein and Its Effect on the Proteome
por: Mehrabian, Mohadeseh, et al.
Publicado: (2014) -
Evolutionary Descent of Prion Genes from the ZIP Family of Metal Ion Transporters
por: Schmitt-Ulms, Gerold, et al.
Publicado: (2009)